Attended Indiana University School of Law and Indiana State University
Hall invests in publicly held corporate equity, specifically common stock, options, and exchange traded funds or ETFs. He primarily focuses on innovative growth, such as late-stage drug development, clean energy and infrastructure (clean water), as well as select commodities and currencies. He also seeks out potential growth and value opportunities across other sectors, industries, and emerging markets.
As exhibited in his published articles, blog posts and comments at Seeking Alpha and other outlets, Hall’s analysis is in-depth and straightforward. He strives to be well-prepared. He maintains the focus required to ensure that meaningful results are achieved. Hall’s public track record speaks for itself.
After publishing his findings in articles and blog posts on Ariad Pharmaceuticals (ARIA), Spectrum Pharmaceuticals (SPPI), SmartHeat (HEAT), and other companies, friends and readers encouraged Hall to establish his own site. So, he presented the idea to other readers on his blog. Both the number of responses and positive feedback exceeded expectations and thereby justified start-up.
Fall 2009, Hall set out to build a resourceful site to provide like-minded investors with unique content and tools. After several months of preparation, Rx Investors was launched in March 2010.
Rx Investors Site Objectives: Help members to (1) avoid pitfalls, (2) generate more meaningful results, and (3) become better, more confident investors in a high risk-high reward environment.
